News

share

NBTXR3 is an aqueous suspension of hafnium oxide nanoparticles being developed for direct injection into cancerous tumours, and...

share

The move is part of Eisai China’s goal to bolster the production efficiency and stable supply chain of...

share

US-based Syapse has formed a strategic alliance with Roche to accelerate product development and clinical delivery for offering...

share

Martine Clozel, M.D. and Chief Scientific Officer of Idorsia, commented: "The preclinical data we have generated leads us...

share

Boehringer Ingelheim has signed a commercial supply agreement for biotechnology firm BeiGene’s tislelizumab. Tislelizumab is an investigational humanised...

share

The global ‘smart pill’ market is expected to be worth $3bn by the year 2025, according to new...

share

The Torque platform makes it possible to anchor powerful stimulatory cytokines, antibodies, and small molecules directly to immune...

share

The partnership is set to discover and develop compounds for various undisclosed G-protein coupled receptor (GPCR) targets. It...